Aeglea BioTherapeutics

Drugs for the treatment of tumors the company was incorporated in 2013 and is based in texas.

HQ location

Austin, United States

Website

Launch date

2013

Employees

Market cap

Enterprise value

$625m

Share price

$16.72 AGLE

Recent deals

Spyre Therapeutics

https://twitter.com/aegleabio https://www.linkedin.com/company/aeglea-biotherapeutics/

Authorizing premium user...